(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved Takeda Pharmaceutical Co Ltd’s Livtencity for a common type of post-transplant infection.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)
U.S. FDA approves Takeda’s drug for post-transplant infection
Nov 23, 2021 | 5:21 PM
Current Weather
7-Day Forecast »
Terre Haute, IN, USA
65 °F Light Rain
Now Playing
100.7 MIX-FM | Today's Hit Music | Terre Haute, IN
